Abstract
The tropomyosin receptor kinase A (TrkA) family of receptor tyrosine kinases (RTKs) emerge as a potential target for glioblastoma (GBM) treatment. Ben......
小提示:本篇文献需要登录阅读全文,点击跳转登录